Digital 'twins' cut surgery time for children with severe hip deformities
23 March, 2022Dr Martina Barzan and her team have created digital 'twins' of child patients that would enable surgeons to better plan, test and execute complex surgeries.
How deceased ovarian cancer patients are safeguarding their families' health
21 March, 2022A new Peter Mac-led study has posthumously tested samples from ovarian cancer patients who missed the chance for genetic testing before they died of the disease.
How antimicrobial resistance spreads inside the human gut
21 March, 2022A collaboration between the Hudson Institute of Medical Research and the Wellcome Sanger Institute, Cambridge UK, explores how antimicrobial resistance (AMR) spreads inside the human gut.
COVID-19 taskforce publishes new risk classification tool
21 March, 2022The National COVID-19 Clinical Evidence Taskforce (NCCET) has developed a risk classification tool to guide clinicians making decisions about which people are most likely to benefit from drugs.
World-first lung scanner installed at the Prince of Wales Hospital
18 March, 2022The world's first dedicated lung scanner, XV Scanner, developed by local researcher Dr Andreas Fouras, has been installed at the Prince of Wales Hospital, Sydney.
WA pharmacist recognised for leadership, contribution to medical safety
16 March, 2022Kerry Fitzsimons has been recognised by the Society of Hospital Pharmacists of Australia (SHPA) for her leadership and contribution to medical safety in Western Australia and beyond.
Locally developed screening tool detects autism at 11 months
14 March, 2022A new screening tool, developed by researchers from La Trobe University, helps detect autism in very young children.
Shingrix approved for Australians 18+ at high risk
14 March, 2022GSK Australia's Shingrix is available on the private market for the prevention of shingles and post-herpetic neuralgia in people aged 18 years and over who are at increased risk of shingles.
2022 influenza control: virologist recommends four actions
09 March, 2022With the lifting of border restrictions and quarantine regulations, Australians can anticipate the reintroduction of influenza, according to the authors of an editorial published by the Medical Journal of Australia.
Cell-based influenza vaccine approved for kids 2+
09 March, 2022Cell-based seasonal influenza vaccine Flucelvax Quad has been approved for Australian children aged two years and older.
Mild COVID-19 linked to changes in brain structure: study
09 March, 2022New research reveals the damaging effects of COVID-19 and improves our understanding of how the disease spreads through the central nervous system.
SHPA releases pharmacy standard for heart disease
08 March, 2022The new pharmacy practice standard recommends patient to pharmacist ratios and quality improvement indicators specific to specialist cardiology pharmacists.
Hepatitis B: new recommendations for clinicians
07 March, 2022New recommendations for the management of hepatitis B have been released in a bid to improve awareness of chronic hepatitis B among clinicians and to increase detection of cases that currently remain undiagnosed.
Royal Victorian Eye and Ear Hospital implements PSML
07 March, 2022The Royal Victorian Eye and Ear Hospital is said to be the first hospital in Australia to implement the Pharmacist Shared Medicines List medicine safety initiative.
Landmark clinical practice guidelines for children with CMT
04 March, 2022Charcot-Marie-Tooth disease is the most common childhood inherited nerve disorder. Yet until now, there have been no guidelines to help patients manage their condition.
